These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37446240)

  • 21. Nontuberculous Mycobacteria, Macrophages, and Host Innate Immune Response.
    Shamaei M; Mirsaeidi M
    Infect Immun; 2021 Jul; 89(8):e0081220. PubMed ID: 34097459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgA Serological Response for the Diagnosis of Mycobacterium abscessus Infections in Patients with Cystic Fibrosis.
    Le Moigne V; Roux AL; Mahoudo H; Christien G; Ferroni A; Dumitrescu O; Lina G; Bouchara JP; Plésiat P; Gaillard JL; Canaan S; Héry-Arnaud G; Herrmann JL
    Microbiol Spectr; 2022 Jun; 10(3):e0019222. PubMed ID: 35583329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus.
    Madani A; Negatu DA; El Marrouni A; Miller RR; Boyce CW; Murgolo N; Bungard CJ; Zimmerman MD; Dartois V; Gengenbacher M; Olsen DB; Dick T
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0066922. PubMed ID: 36005813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary characterization of a Mycobacterium abscessus mutant in human and murine models of infection.
    Byrd TF; Lyons CR
    Infect Immun; 1999 Sep; 67(9):4700-7. PubMed ID: 10456919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating Nontuberculous Mycobacteria Transmission at the Colorado Adult Cystic Fibrosis Program.
    Gross JE; Caceres S; Poch K; Hasan NA; Jia F; Epperson LE; Lipner E; Vang C; Honda JR; Strand M; Calado Nogueira de Moura V; Daley CL; Strong M; Davidson RM; Nick JA
    Am J Respir Crit Care Med; 2022 May; 205(9):1064-1074. PubMed ID: 35085056
    [No Abstract]   [Full Text] [Related]  

  • 26. Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessus.
    Yang JJ; Goff A; Wild DJ; Ding Y; Annis A; Kerber R; Foote B; Passi A; Duerksen JL; London S; Puhl AC; Lane TR; Braunstein M; Waddell SJ; Ekins S
    Tuberculosis (Edinb); 2024 May; 146():102500. PubMed ID: 38432118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycobacterium abscessus resists the innate cellular response by surviving cell lysis of infected phagocytes.
    Touré H; Galindo LA; Lagune M; Glatigny S; Waterhouse RM; Guénal I; Herrmann JL; Girard-Misguich F; Szuplewski S
    PLoS Pathog; 2023 Mar; 19(3):e1011257. PubMed ID: 36972320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biaryl amide compounds reduce the inflammatory response in macrophages by regulating Dectin-1.
    Hyung KE; Lee MJ; Lee YJ; Lee DI; Min HY; Park SY; Min KH; Hwang KW
    Int Immunopharmacol; 2016 Mar; 32():125-132. PubMed ID: 26828762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Description of wylie-stanley agar for the recovery of
    Moore JE; Murphy A; Millar BC
    Int J Mycobacteriol; 2021; 10(2):166-169. PubMed ID: 34558469
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus
    Sarathy JP; Zimmerman MD; Gengenbacher M; Dartois V; Dick T
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0123722. PubMed ID: 36350151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinically relevant mutations in the PhoR sensor kinase of host-adapted
    Belardinelli JM; Arora D; Avanzi C; Wheat WH; Bryant JM; Spencer JS; Blundell TL; Parkhill J; Floto RA; Jackson M
    Microbiol Spectr; 2023 Dec; 11(6):e0158823. PubMed ID: 37874174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against
    Lee DG; Hwang YH; Park EJ; Kim JH; Ryoo SW
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681686
    [No Abstract]   [Full Text] [Related]  

  • 34. Preclinical murine models to study lung infection with Mycobacterium abscessus complex.
    Nicola F; Cirillo DM; Lorè NI
    Tuberculosis (Edinb); 2023 Jan; 138():102301. PubMed ID: 36603391
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
    Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus.
    Negatu DA; Beuchel A; Madani A; Alvarez N; Chen C; Aragaw WW; Zimmerman MD; Laleu B; Gengenbacher M; Dartois V; Imming P; Dick T
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0067621. PubMed ID: 34001512
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Sur S; Patra T; Karmakar M; Banerjee A
    Crit Rev Microbiol; 2023 Aug; 49(4):499-514. PubMed ID: 35696783
    [No Abstract]   [Full Text] [Related]  

  • 38.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0068922. PubMed ID: 35943269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colony morphotype governs innate and adaptive pulmonary immune responses to Mycobacterium abscessus infection in C3HeB/FeJ mice.
    Ferrell KC; Stewart EL; Counoupas C; Triccas JA
    Eur J Immunol; 2024 Jul; 54(7):e2350610. PubMed ID: 38576227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omadacycline for management of Mycobacterium abscessus infections: a review of its effectiveness, place in therapy, and considerations for use.
    Rizzo AR; Moniri NH
    BMC Infect Dis; 2022 Nov; 22(1):874. PubMed ID: 36419143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.